Glycolysis inhibition decreases the levels of glutamate transporters and enhances glutamate neurotoxicity in the R6/2 Huntington's disease mice

Neurochemical Research

Volumn 35, Issue 8, 2010, Pages 1156-1163

  Estrada Sánchez, Ana María ^a   Montiel, Teresa ^a   Massieu, Lourdes ^a  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

Excitotoxicity; GAPDH; GLAST; GLT 1; Iodoacetate

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE TRANSPORTER; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP); IODOACETIC ACID; SODIUM GLUCOSE COTRANSPORTER 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME INHIBITION; EXCITOTOXICITY; FEMALE; GLYCOLYSIS; HIPPOCAMPUS; HISTOPATHOLOGY; HUNTINGTON CHOREA; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; BRAIN; FEMALE; GLUTAMIC ACID; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); GLYCOLYSIS; HUNTINGTON DISEASE; IODOACETATES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC;

ANIMALIA; MUS; RATTUS;

EID: 77955557496     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0168-5     Document Type: Article

References (48)

1. The Huntington's Disease Collaborative Research Group 1993 A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes Cell 72 971 983 10.1016/0092-8674(93)90585-E (Pubitemid 23110238)
2. GA Graveland RS Williams M DiFiglia 1985 Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease Science 227 770 773 10.1126/science.3155875 1:STN:280:DyaL2M7hsFersw%3D%3D 3155875
3. JP Vonsattel RH Myers TJ Stevens, et al. 1985 Neuropathological classification of Huntington's disease J Neuropathol Exp Neurol 44 559 577 10.1097/00005072-198511000-00003 1:STN:280:DyaL28%2Fjs1egsg%3D%3D 2932539
4. EG McGeer PL McGeer 1976 Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids Nature 263 517 519 10.1038/263517a0 1:CAS:528:DyaE2sXmvFGnsA%3D%3D 9592
5. R Schwarcz WO Whetsell RM Mangano 1983 Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain Science 219 316 318 10.1126/science.6849138 1:CAS:528:DyaL3sXmvF2gsQ%3D%3D 6849138
6. T Arzberger K Krampfl S Leimgruber, et al. 1997 Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT-1) mRNA expression in Huntington's disease-an in situ hybridization study J Neuropathol Exp Neurol 56 440 454 10.1097/00005072-199704000-00013 1:STN:280:DyaK2s3lsFehug%3D%3D 9100675
7. B Nicniocaill B Haraldsson O Hansson, et al. 2001 Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice Eur J Neurosci 13 206 210 10.1046/j.0953-816X.2000.01379.x 1:STN:280:DC%2BD3M7jt1KhtQ%3D%3D 11135020 (Pubitemid 32055881)
8. JC Liévens B Woodman A Mahal, et al. 2001 Impaired glutamate uptake in the R6 Huntington's disease transgenic mice Neurobiol Dis 8 807 821 10.1006/nbdi.2001.0430 11592850 (Pubitemid 33055597)
9. PF Behrens P Franz B Woodman, et al. 2002 Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation Brain 125 1908 1922 10.1093/brain/awf180 1:STN:280:DC%2BD38zoslajtw%3D%3D 12135980
10. JY Shin ZH Fang ZX Yu, et al. 2005 Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity J Cell Biol 171 1001 1012 10.1083/jcb.200508072 1:CAS:528:DC%2BD2MXhtlequ7fF 16365166 (Pubitemid 41815832)
11. B Hassel S Tessler RL Faull, et al. 2008 Glutamate uptake is reduced in prefrontal cortex in Huntington's disease Neurochem Res 33 232 237 10.1007/s11064-007-9463-1 1:CAS:528:DC%2BD1cXps1WntA%3D%3D 17726644
12. BR Miller JL Dorner M Shou, et al. 2008 Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse Neuroscience 153 329 337 10.1016/j.neuroscience.2008.02.004 1:CAS:528:DC%2BD1cXkvVOkurg%3D 18353560
13. AM Estrada-Sánchez T Montiel J Segovia, et al. 2009 Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters Neurobiol Dis 34 78 86 10.1016/j.nbd.2008.12.017 19168136
14. D Attwell SB Laughlin 2001 An energy budget for signaling in the grey matter of the brain J Cereb Blood Flow Metab 21 1133 1145 10.1097/00004647- 200110000-00001 1:CAS:528:DC%2BD3MXot1Ggsbc%3D 11598490
15. L Pellerin PJ Magistretti 1994 Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization Proc Natl Acad Sci USA 91 10625 10629 10.1073/pnas.91.22.10625 1:CAS:528:DyaK2cXmvFentr8%3D 7938003 (Pubitemid 24329051)
16. RA Swanson J Chen SH Graham 1994 Glucose can fuel glutamate uptake in ischemic brain J Cereb Blood Flow Metab 14 1 6 1:CAS:528:DyaK2cXis1OgtrY%3D 7903308
17. A Loaiza OH Porras LF Barros 2003 Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy J Neurosci 23 7337 7342 1:CAS:528:DC%2BD3sXms1Wntr8%3D 12917367
18. R Debernardi PJ Magistretti L Pellerin 1999 Trans-inhibition of glutamate transport prevents excitatory amino acid-induced glycolysis in astrocytes Brain Res 850 39 46 10.1016/S0006-8993(99)02022-3 1:CAS:528:DC%2BD3cXjtVagtw%3D%3D 10629746
19. N Cholet L Pellerin E Welker, et al. 2001 Local injection of antisense oligonucleotides targeted to the glial glutamate transporter GLAST decreases the metabolic response to somatosensory activation J Cereb Blood Flow Metab 21 404 412 10.1097/00004647-200104000-00009 1:CAS:528:DC%2BD3MXntFKisr4%3D 11323526
20. T Gemba T Oshima M Ninomiya 1994 Glutamate efflux via the reversal of the sodium-dependent glutamate transporter caused by glycolytic inhibition in rat cultured astrocytes Neuroscience 63 789 795 10.1016/0306-4522(94)90523-1 1:CAS:528:DyaK2MXisFequrc%3D 7898678 (Pubitemid 24360231)
21. T Ogata Y Nakamura K Tsuji, et al. 1995 A possible mechanism for the hypoxia-hypoglycemia-induced release of excitatory amino acids from cultured hippocampal astrocytes Neurochem Res 20 737 743 10.1007/BF01705543 1:CAS:528:DyaK2MXms1CgsLs%3D 7566371
22. A Camacho T Montiel L Massieu 2006 The anion channel blocker, 4, 4'-dinitrostilbene-2, 2'-disulfonic acid prevents neuronal death and excitatory amino acid release during glycolysis inhibition in the hippocampus in vivo Neuroscience 142 1005 1017 10.1016/j.neuroscience.2006.07.004 1:CAS:528:DC%2BD28XhtFCjsLfN 16920271 (Pubitemid 44636054)
23. K Hernández-Fonseca L Massieu 2005 Disruption of endoplasmic reticulum calcium stores is involved in neuronal death induced by glycolysis inhibition in cultured hippocampal neurons J Neurosci Res 82 196 205 10.1002/jnr.20631 16175570 (Pubitemid 41648758)
24. L Massieu ML Haces T Montiel, et al. 2003 Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition Neuroscience 120 365 378 10.1016/S0306-4522(03)00266-5 1:CAS:528:DC%2BD3sXlvVCltr8%3D 12890508 (Pubitemid 37288773)
25. MI Sabri S Ochs 1971 Inhibition of glyceraldehyde-3-phosphate dehydrogenase in mammalian nerve by iodoacetic acid J Neurochem 18 1509 1514 10.1111/j.1471-4159.1971.tb00013.x 1:CAS:528:DyaE3MXltVOiu7Y%3D 4398402
26. K Hernández-Fonseca N Cárdenas-Rodríguez J Pedraza-Chaverri, et al. 2008 Calcium-dependent production of reactive oxygen species is involved in neuronal damage induced during glycolysis inhibition in cultured hippocampal neurons J Neurosci Res 86 1768 1780 10.1002/jnr.21634 18293416 (Pubitemid 351859427)
27. MM Schmidt R Dringen 2009 Differential effects of iodoacetamide and iodoacetate on glycolysis and glutathione metabolism of cultured astrocytes Front Neuroenergetics 1 1 10 19584905
28. N Cárdenas-Rodríguez S Guzmán-Beltrán ON Medina-Campos, et al. 2009 The effect of nordihydroguaiaretic acid on iodoacetate-induced toxicity in cultured neurons J Biochem Mol Toxicol 23 137 142 10.1002/jbt.20278 19367647
29. A Camacho T Montiel L Massieu 2007 Sustained metabolic inhibition induces an increase in the content and phosphorylation of the NR2B subunit of N-methyl-D-aspartate receptors and a decrease in glutamate transport in the rat hippocampus in vivo Neuroscience 30 873 886 10.1016/j.neuroscience.2006.12.069 (Pubitemid 46441654)
30. L Massieu N Gómez-Román T Montiel 2000 In vivo potentiation of glutamate-mediated neuronal damage after chronic administration of the glycolysis inhibitor iodoacetate Exp Neurol 165 257 267 10.1006/exnr.2000.7481 1:CAS:528:DC%2BD3cXmsFemtLg%3D 10993686
31. J Mejía-Toiber T Montiel L Massieu 2006 D-beta-hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition in vivo Neurochem Res 31 1399 1408 10.1007/s11064-006- 9189-5 17115265 (Pubitemid 44900579)
32. RT Matthews RJ Ferrante BG Jenkins, et al. 1997 Iodoacetate produces striatal excitotoxic lesions J Neurochem 69 285 289 1:CAS:528:DyaK2sXktV2msL4%3D 9202321
33. M Sandberg B Nyström A Hamberger 1985 Metabolically derived aspartate-elevated extracellular levels in vivo in iodoacetate poisoning J Neurosci Res 13 489 495 10.1002/jnr.490130403 1:CAS:528:DyaL2MXkt1Sksb0%3D 4009740 (Pubitemid 15049656)
34. WJ Powers TO Videen J Markham, et al. 2007 Selective defect of in vivo glycolysis in early Huntington's disease striatum Proc Natl Acad Sci USA 104 2945 2949 10.1073/pnas.0609833104 1:CAS:528:DC%2BD2sXisVSmsLk%3D 17299049 (Pubitemid 46327983)
35. BG Jenkins HD Rosas YC Chen, et al. 1998 1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers Neurology 50 1357 1365 1:STN:280:DyaK1c3lsFChtA%3D%3D 9595987
36. JR Burke JJ Enghild ME Martin, et al. 1996 Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH Nat Med 2 347 350 10.1038/nm0396-347 1:CAS:528:DyaK28XhsVGktL4%3D 8612237 (Pubitemid 26082013)
37. BI Bae MR Hara MB Cascio, et al. 2006 Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH Proc Natl Acad Sci USA 103 3405 3409 10.1073/pnas.0511316103 1:CAS:528:DC%2BD28XksF2kurg%3D 16492755 (Pubitemid 43346481)
38. Paxinos G, Franklin KJ (2004) The mouse brain in stereotaxic coordinates. Elsevier Academic Press, San Diego
39. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254 10.1016/0003-2697(76)90527-3 1:CAS:528: DyaE28XksVehtrY%3D 942051
40. VV Senatorov V Charles PH Reddy, et al. 2003 Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington's disease Mol Cell Neurosci 22 285 297 10.1016/S1044- 7431(02)00013-1 1:CAS:528:DC%2BD3sXis1yqt7w%3D 12691731 (Pubitemid 36407592)
41. SJ Kish I Lopes-Cendes M Guttman, et al. 1998 Brain glyceraldehyde-3- phosphate dehydrogenase activity in human trinucleotide repeat disorders Arch Neurol 55 1299 1304 10.1001/archneur.55.10.1299 1:STN:280:DyaK1cvltV2gtA%3D%3D 9779656 (Pubitemid 28465861)
42. SE Browne AC Bowling U MacGarvey, et al. 1997 Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia Ann Neurol 41 646 653 10.1002/ana.410410514 1:CAS:528: DyaK2sXjsF2qtLs%3D 9153527 (Pubitemid 27212659)
43. AJ Cooper KF Sheu JR Burke, et al. 1998 Glyceraldehyde-3-phosphate dehydrogenase abnormality in metabolically stressed Huntington disease fibroblasts Dev Neurosci 20 462 468 10.1159/000017344 1:CAS:528: DyaK1cXntl2ltrc%3D 9778585 (Pubitemid 28495542)
44. AJ Morton W Leavens 2000 Mice transgenic for the human Huntington's disease mutation have reduced sensitivity to kainic acid toxicity Brain Res Bull 52 51 59 10.1016/S0361-9230(00)00238-0 1:CAS:528:DC%2BD3cXisFGqtr8%3D 10779703 (Pubitemid 30211629)
45. GA MacGibbon LC Hamilton SF Crocker, et al. 2002 Immediate-early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice J Neurosci Res 67 372 378 10.1002/jnr.10100 1:CAS:528:DC%2BD38Xht1OmsL8%3D 11813242 (Pubitemid 34137144)
46. O Hansson E Guatteo NB Mercuri, et al. 2001 Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene Eur J Neurosci 14 1492 1504 10.1046/j.0953-816x.2001.01767.x 1:STN:280:DC%2BD3MnovFartg%3D%3D 11722611 (Pubitemid 35463716)
47. TS Tang H Tu PC Orban, et al. 2004 HAP1 facilitates effects of mutant huntingtin on inositol 1, 4, 5-trisphosphate-induced Ca release in primary culture of striatal medium spiny neurons Eur J Neurosci 7 1779 1787 10.1111/j.1460-9568.2004.03633.x (Pubitemid 39471571)
48. J Schiefer A Sprünken C Puls, et al. 2004 The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease Brain Res 1019 246 254 10.1016/j.brainres.2004.06.005 1:CAS:528:DC%2BD2cXmslemsbg%3D 15306259 (Pubitemid 39078630)